CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 54 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $237,000 | +315.8% | 85,907 | +58.5% | 0.01% | +600.0% |
Q4 2016 | $57,000 | +533.3% | 54,200 | +321.3% | 0.00% | – |
Q2 2016 | $9,000 | -25.0% | 12,865 | +26.8% | 0.00% | – |
Q1 2016 | $12,000 | -82.4% | 10,146 | -63.2% | 0.00% | -100.0% |
Q4 2015 | $68,000 | -55.3% | 27,560 | -45.7% | 0.00% | -50.0% |
Q3 2015 | $152,000 | +78.8% | 50,800 | +147.4% | 0.00% | 0.0% |
Q2 2015 | $85,000 | -10.5% | 20,535 | -34.4% | 0.00% | +100.0% |
Q3 2013 | $95,000 | – | 31,287 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |